SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Research and development spending
3Y CAGR
-2.0%/yr
Annual compound
5Y CAGR
+4.2%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $34.31M | +13.7% |
| 2024 | $30.16M | +82.7% |
| 2023 | $16.52M | -54.7% |
| 2022 | $36.44M | -36.3% |
| 2021 | $57.18M | +104.9% |
| 2020 | $27.91M | +248.0% |
| 2019 | $8.02M | - |